1[1]McCabe DJH,Brown MM. Prevention of ischaemic strokeantiplatelets[J]. Br Med Bull,2000,56:510-525.
2[2]Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing physicians' health study[J]. N Engl J Med,1989,321:129-135.
3[3]Peto R,Gray R,Collins R,et al. Randomised trail of prophylactic daily aspirin in British male doctors[J]. Br Med J,1988,296:313-316.
4[4]ETDRS Investigators. Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14[J]. JAMA,1992,268(10):1292-1300.
5[5]The Medical Research Council's General Practice Research Framework. Thrombosis prevention trial:randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk[J]. Lancet,1998,351(9098):233-241.
6[6]Meade TW,Brennan PJ. Determination of who may derive most benefit from aspirin in prevention:subgroup results from a randomised controlled trial[J]. BMJ,2000,321:13-17.
7[7]Hansson L,Zanchetti A,Carruthers SG,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:principal results of the Hypertension Optimal Treatment(HOT)randomised trial[J]. Lancet,1998,351(9118):1755-1762.
8[8]Kjeldsen SE,Kolloch RE,Leonetti G,et al. Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. Hypertension Optimal Treatment[J]. J Hypertens,2000,18(5):629-642.
9[9]Kronmal RA,Hart RG,Manolio TA,et al. Aspirin use and incident stroke in the cardiovascular health study[J]. Stroke,1998,29:887-894.
10[10]Iso H,Hennekens CH,Stampfer MJ,et al. Prospective study of aspirin use and risk of stroke in women[J]. Stroke,1999,30(9):1764-1771.
